Hansoh Pharmaceutical Group Dividendos y recompras
Dividendo controles de criterios 2/6
Hansoh Pharmaceutical Group es una empresa que paga dividendos con una rentabilidad actual de 2.09% que está bien cubierta por los beneficios.
Información clave
2.1%
Rentabilidad por dividendo
0.03%
Rendimiento de la recompra
| Rendimiento total para el accionista | 2.1% |
| Rendimiento futuro de los dividendos | 1.1% |
| Crecimiento de los dividendos | 53.0% |
| Próxima fecha de pago de dividendos | n/a |
| Fecha ex dividendo | n/a |
| Dividendo por acción | HK$0.402 |
| Ratio de pago | 40% |
Últimas actualizaciones de dividendos y recompras
Recent updates
Hansoh Pharmaceutical Group (HKG:3692) Seems To Use Debt Rather Sparingly
Nov 21
Is Now The Time To Put Hansoh Pharmaceutical Group (HKG:3692) On Your Watchlist?
Nov 04Estimating The Fair Value Of Hansoh Pharmaceutical Group Company Limited (HKG:3692)
Aug 28Pinning Down Hansoh Pharmaceutical Group Company Limited's (HKG:3692) P/E Is Difficult Right Now
Aug 07If EPS Growth Is Important To You, Hansoh Pharmaceutical Group (HKG:3692) Presents An Opportunity
Jul 16Hansoh Pharmaceutical Group (HKG:3692) Could Easily Take On More Debt
Jun 24Hansoh Pharmaceutical Group Company Limited's (HKG:3692) CEO Will Probably Find It Hard To See A Huge Raise This Year
Jun 06Estimating The Intrinsic Value Of Hansoh Pharmaceutical Group Company Limited (HKG:3692)
May 23Hansoh Pharmaceutical Group Company Limited Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions
May 01Do Hansoh Pharmaceutical Group's (HKG:3692) Earnings Warrant Your Attention?
Mar 28There's Reason For Concern Over Hansoh Pharmaceutical Group Company Limited's (HKG:3692) Massive 28% Price Jump
Mar 04An Intrinsic Calculation For Hansoh Pharmaceutical Group Company Limited (HKG:3692) Suggests It's 28% Undervalued
Feb 16Hansoh Pharmaceutical Group (HKG:3692) Seems To Use Debt Quite Sensibly
Dec 08Hansoh Pharmaceutical Group Company Limited (HKG:3692) Shares Could Be 25% Below Their Intrinsic Value Estimate
Oct 12Hansoh Pharmaceutical Group's (HKG:3692) Upcoming Dividend Will Be Larger Than Last Year's
Sep 14These 4 Measures Indicate That Hansoh Pharmaceutical Group (HKG:3692) Is Using Debt Reasonably Well
Sep 09Calculating The Intrinsic Value Of Hansoh Pharmaceutical Group Company Limited (HKG:3692)
Jul 10These 4 Measures Indicate That Hansoh Pharmaceutical Group (HKG:3692) Is Using Debt Reasonably Well
Jun 11Calculating The Fair Value Of Hansoh Pharmaceutical Group Company Limited (HKG:3692)
Jan 23Hansoh Pharmaceutical Group (HKG:3692) Has A Rock Solid Balance Sheet
Dec 01Hansoh Pharmaceutical Group Company Limited's (HKG:3692) Intrinsic Value Is Potentially 65% Above Its Share Price
Oct 19Hansoh Pharmaceutical Group (HKG:3692) Could Easily Take On More Debt
Aug 28An Intrinsic Calculation For Hansoh Pharmaceutical Group Company Limited (HKG:3692) Suggests It's 44% Undervalued
Jun 09Hansoh Pharmaceutical Group Company Limited's (HKG:3692) Popularity With Investors Is Under Threat From Overpricing
May 19Is Hansoh Pharmaceutical Group (HKG:3692) A Risky Investment?
Apr 22An Intrinsic Calculation For Hansoh Pharmaceutical Group Company Limited (HKG:3692) Suggests It's 45% Undervalued
Feb 06Estabilidad y crecimiento de los pagos
Obteniendo datos sobre dividendos
Dividendo estable: Aunque el pago de dividendos se ha mantenido estable, 3692 lleva pagando dividendos menos de 10 años.
Dividendo creciente: El pago de dividendos de 3692 ha aumentado, pero la empresa sólo ha pagado dividendos durante 4 años.
Rentabilidad por dividendo vs. Mercado
| Rentabilidad por dividendo de Hansoh Pharmaceutical Group vs. Mercado |
|---|
| Segmento | Rentabilidad por dividendo |
|---|---|
| Empresa (3692) | 2.1% |
| Suelo de mercado 25% (HK) | 3.3% |
| Techo de mercado 25% (HK) | 8.1% |
| Media de la industria (Pharmaceuticals) | 3.8% |
| Analista de previsiones (3692) (hasta 3 años) | 1.1% |
Dividendo destacado: El dividendo de 3692(2.09%) no es notable en comparación con el 25% inferior de pagadores de dividendos del mercado Hong Kong (3.3%).
Alto dividendo: El (2.09%) del dividendo de 3692 es bajo en comparación con el 25% de los principales pagadores de dividendos del mercado Hong Kong (8.06%).
Pago de beneficios a los accionistas
Cobertura de los beneficios: Con su razonablemente bajo ratio de pago (39.6%), los pagos de dividendos de 3692 están bien cubiertos por los beneficios.
Pago en efectivo a los accionistas
Cobertura de flujo de caja: Con su razonable ratio de pago en efectivo (52%), los pagos de dividendos de 3692 están cubiertos por los flujos de caja.